Cargando…
Risk of Thromboembolic Events and Associated Healthcare Costs in Patients with Inflammatory Bowel Disease
INTRODUCTION: Inflammatory bowel disease (IBD) is associated with greater risk of thromboembolic events (TEs) due to the link between systemic inflammation and hypercoagulability. This study assessed the rates of TEs among patients with IBD versus patients without immune-mediated disease (IMD) and t...
Autores principales: | Setyawan, Juliana, Mu, Fan, Zichlin, Miriam L., Billmyer, Emma, Downes, Nathaniel, Yang, Hongbo, Azimi, Nassir, Strand, Vibeke, Yarur, Andres |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8799565/ https://www.ncbi.nlm.nih.gov/pubmed/34877631 http://dx.doi.org/10.1007/s12325-021-01973-7 |
Ejemplares similares
-
The Economic Burden of Thromboembolic Events Among Patients with Immune-Mediated Diseases
por: Setyawan, Juliana, et al.
Publicado: (2021) -
Reporting of Thromboembolic Events with JAK Inhibitors: Analysis of the FAERS Database 2010–2019
por: Setyawan, Juliana, et al.
Publicado: (2021) -
Inflammatory bowel disease and thromboembolic events: a c’lot to
learn
por: Carvalho, Ana Catarina, et al.
Publicado: (2022) -
Thromboembolic Events in Patients with Inflammatory Bowel Disease
por: Algahtani, Farjah H., et al.
Publicado: (2016) -
Safety of Janus Kinase Inhibitors in Inflammatory Bowel Diseases
por: Núñez, Paulina, et al.
Publicado: (2023)